News

Vinay Prasad, a top regulator at the US Food and Drug Administration, has left the agency after a controversy over his ...
Sarepta and Capricor learned of key regulatory decisions from the media and investors, and Duchenne muscular dystrophy ...
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
Journal Editorial Report: Vinay Prasad exits after gene-therapy reversal. Why Britain faces a bigger Trump tariff blow ...
Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...